4 Discussion The improvement of semaglutide on obese individuals is significant, and the main mechanism of this type of GLP-1RA is to stimulate GLP-1R, triggering activation of several metabolic pathways involved in insulin secretion, lipid metabolism, energy expenditure, cell survival, anti-apoptotic signaling, and oxidative stress prevention in tissues such as the pancreas, central nervous system, heart, muscles, kidneys, and intestines ( We found that intraperitoneal injection of 100 g/kgbw of semaglutide every other day significantly improved the abnormal weight gain induced by a high-fat diet, reduced the proportion of white adipose tissue in the groin and epididymis
Do not double up doses
Patients with certain conditions, including MEN2, medullary thyroid carcinoma, or pregnancy, may not be eligible
Funding statement Departmental only